Peptides derived from human C‐reaetive protein inhibit the enzymatic activities of human leukocyte elastase and cathepsin G: use of overlapping peptide sequences to identify a unique inhibitor
- 1 April 1998
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 51 (4) , 282-289
- https://doi.org/10.1111/j.1399-3011.1998.tb00425.x
Abstract
Ten overlapping 15-mer peptides, spanning the entire inner disulfide loop of human C-reactive protein (residues 36-97), were used to isolate a potent inhibitor of the enzymes human leukocyte elastase and human leukocyte cathepsin G, which are associated with chronic inflammatory tissue damage. In contrast to the inability of intact C-reactive protein to inhibit both enzymes, the synthetic peptide E62ILIFWSKDIGYSFT76 inhibited leukocyte elastase (Ki= 0.18 μm) and cathepsin G (Ki= 0.25 μm) at concentrations far lower than the acute-phase concentration of C-reactive protein. Several peptide-enzyme binding motifs were elucidated by structure-function studies, with the Glu62 residue being crucial in establishing long-range subsite interactions. Peptides derived from C-reactive protein, which may be generated in vivo by neutrophil-mediated proteolysis as part of a complex regulatory homeostatic mechanism, may play an important role in regulating the activity of matrix-degrading enzymes, specifically at sites of inflammation. The present results thus may shed additional insight on the physiological functions of the major acute-phase reactant C-reactive protein, and perhaps be used as a basis for the design of novel therapeutic substances.Keywords
This publication has 25 references indexed in Scilit:
- Synthetic peptides derived from the sequence of human C‐reactive protein inhibit the enzymatic activities of human leukocyte elastase and human leukocyte cathepsin GInternational Journal of Peptide and Protein Research, 1996
- Three dimensional structure of human C-reactive proteinNature Structural & Molecular Biology, 1996
- The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A proteinImmunology Today, 1994
- Characterization of neutrophil-mediated degradation of human C-reactive protein and identification of the proteaseClinical and Experimental Immunology, 1992
- Human leukocyte and porcine pancreatic elastase: x-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitorsBiochemistry, 1989
- The refined 2.3 Å crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitorFEBS Letters, 1988
- Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunitMolecular Immunology, 1987
- Inhibitors of leukocyte elastase and leukocyte Cathepsin G. Agents for the treatment of emphysema and related ailmentsMedicinal Research Reviews, 1987
- Binding of C‐reactive protein to human neutrophilsFEBS Letters, 1987
- Catalysis by human leukocyte elastase. Role of secondary-subsite interactionsJournal of the American Chemical Society, 1985